How “Voices” Offers a New Avenue of Connection for the Chronic Illness and Rare Disease Communities

It’s no secret that being a part of the chronic illness and/or rare disease community can sometimes be lonely and isolating. Many people, while empathetic to the challenges faced within…

Continue Reading How “Voices” Offers a New Avenue of Connection for the Chronic Illness and Rare Disease Communities
SGT-001 Safety and Efficacy Data Available from IGNITE DMD Clinical Trial
source: pixabay.com

SGT-001 Safety and Efficacy Data Available from IGNITE DMD Clinical Trial

Since its inception, life sciences company Solid Biosciences Inc. has been working to develop treatment options for patients with Duchenne muscular dystrophy (DMD). According to a recent press release, the…

Continue Reading SGT-001 Safety and Efficacy Data Available from IGNITE DMD Clinical Trial
This New Treatment for Mantle Cell Lymphoma has the Potential for Durable Remissions
source: pixabay.com

This New Treatment for Mantle Cell Lymphoma has the Potential for Durable Remissions

  A recent article in The American Journal of Managed Care (AJMC) heralds the approval of a third CAR T-cell therapy, called Tecartus. Kite Pharma’s cell-based gene therapy is the first…

Continue Reading This New Treatment for Mantle Cell Lymphoma has the Potential for Durable Remissions
This New Treatment for Mantle Cell Lymphoma has the Potential for Durable Remissions
source: pixabay.com

This New Treatment for Mantle Cell Lymphoma has the Potential for Durable Remissions

  A recent article in The American Journal of Managed Care (AJMC) heralds the approval of a third CAR T-cell therapy, called Tecartus. Kite Pharma’s cell-based gene therapy is the first…

Continue Reading This New Treatment for Mantle Cell Lymphoma has the Potential for Durable Remissions
New Study Suggests Targeted Next Generation Sequencing Can Aid in Identification of Menkes Disease
source: pixabay.com

New Study Suggests Targeted Next Generation Sequencing Can Aid in Identification of Menkes Disease

  In a recent press release, biopharmaceutical company Fortress Biotech announced that their study regarding ATP7A targeted next generation DNA sequencing for Menkes disease was published in Molecular Genetics and Metabolism…

Continue Reading New Study Suggests Targeted Next Generation Sequencing Can Aid in Identification of Menkes Disease